The herbal drug Catuama reverts and prevents ventricular fibrillation in the isolated rabbit heart

Journal of Electrocardiology

Volumn 40, Issue 6, 2007, Pages 534.e1-534.e8

  Pontieri, Vera ^a   Neto, Augusto Scalabrini ^a   de França Camargo, André Ferrari ^a   Koike, Marcia Kiyomi ^a   Velasco, Irineu Tadeu ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiarrhythmia agents; Fibrillation; Pharmacology; Resuscitation

Indexed keywords

AMIODARONE; CATUAMA; HERBACEOUS AGENT; LIDOCAINE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG EFFECT; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FIBRILLATION; HERB; MALE; NONHUMAN; PAULLINIA CUPANA; PRIORITY JOURNAL; PTYCHOPETALUM OLACOIDES; RABBIT; TREATMENT RESPONSE; TRICHILIA CATIGUA; ZINZIBER OFFICINALIS;

EID: 35748947738     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2007.06.002     Document Type: Article

References (25)

1. Calixto J.B., and Cabrini D.A. Herbal medicine Catuama induces endothelium-dependent and -independent vasorelaxant action on isolated vessels from rats, guinea-pigs and rabbits. Phytother Res 11 (1997) 32
2. Antunes E., Gordo W.M., de Oliveira J.F., Teixeira C.E., Hyslop S., and De Nucci G. The relaxation of isolated rabbit corpus cavernosum by the herbal medicine Catuama and its constituents. Phytother Res 15 (2001) 416
3. Campos M.M., Fernandes E.S., Ferreira J., Bortolanza L.B., Santos A.R., and Calixto J.B. Pharmacological and neurochemical evidence for antidepressant-like effects of the herbal product Catuama. Pharmacol Biochem Behav 78 (2004) 757
4. Barbosa N.R., Fischmann L., Talib L.L., and Gattaz W.F. Catuaba extract inhibit PLA2 activity in human platelets. J Electrocardiol 18 (2004) 942
5. National Institutes of Health. Guide to the use and care of laboratory animals (2003), National Academy Press, Washington, D.C., USA
6. AVMA Panel on Euthanasia-American Veterinary Medical Association. 2000 Report of the AVMA Panel on Euthanasia. JAVMA 218 (2001) 669
7. França Camargo A.F., de Celis A.C.R., Velasco I.T., Pontieri V., and Scalabrini Neto A. New model of ventricular fibrillation. J Electrocardiol 38 (2005) 226
8. Franz M.R. Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc Res 41 (1999) 25
9. Gillium R.F. Sudden coronary death in the United States. Circulation 79 (1989) 756
10. Moe G.K. On the multiple wavelet hypothesis and atrial fibrillation. Arch Int Pharmacodyn Ther 140 (1962) 183
11. Weiss J.N., Garfinkel A., Karagueuzian H.S., et al. Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. Circulation 99 (1999) 2819
12. Chen J., Mandapati R., Berenfeld O., et al. High-frequency periodic sources underlie ventricular fibrillation in the isolated rabbit heart. Circ Res 86 (2000) 86
13. Jalife J., and Gray R. Drifting vortices of electrical waves underlie ventricular fibrillation in the rabbit heart. Acta Physiologica Scandinavica 157 (1996) 123
14. Banville I., Gray R.A., Ideker R.E., and Smith W.M. Shock-induced figure-of-eight reentry in the isolated rabbit heart. Circ Res 85 (1999) 742
15. Lown B., Amarasingham R., and Neuman J. New method for terminating cardiac arrhythmias: use of synchronised capacitor discharge. JAMA 182 (1962) 548
16. International Resuscitation Council. Guidelines. Resuscitation 46 (2000) 109
17. Sado D.M., and Deakin C.D. How good is your defibrillation technique?. J R Soc Med 98 (2005) 3
18. Pepe P.E., Abramson N.S., and Brown C.G. ACLS: does it really work?. Ann Emerg Med 23 (1994) 1037
19. Nelson R. The public defibrillator: mandated in airports but not health clubs and workplaces. Am J Nurs 105 (2005) 25
20. Herzog C.A. Don't forget the defibrillator in the dialysis unit. Nephrol Dial Transplant 19 (2004) 2959
21. Powell J., Van Ottingham L., and Schron E. Public defibrillation: increased survival from a structured response system. J Cardiovasc Nurs 19 (2004) 384
22. Mitka M. Non-prescription defibrillators. JAMA 292 (2004) 1809
23. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877
24. Weiss J.N., Chen P.S., Qu Z., Karagueuzian H.S., and Garfinkel A. Ventricular fibrillation: how do we stop the waves from breaking?. Circ Res 87 (2000) 1103
25. Weiss J.N., Chen P.S., Wu T.J., Siegerman C., and Garfinkel A. Ventricular fibrillation: new insights into mechanisms. Ann N Y Acad Sci 1015 (2004) 122